Finley. Age: 22.
How signicantly can breast cancer prevention drugs lower a woman's risk? Here's a look at the numbers. Many new and potent medicines to prevent breast cancer have become available in the past 20 years. Surprisingly, however, many women—even those at high risk for the disease—are not taking advantage of these medicines.
Emmeline. Age: 31.
Medications for Breast Cancer
Josie. Age: 31.
Drug improves survival in metastatic breast cancer
Skip to Content. Use the menu to see other pages. This section explains the types of treatments that are the standard of care for early-stage and locally advanced breast cancer. When making treatment plan decisions, you are encouraged to consider clinical trials as an option.
Request more information. Ibrance is part of a new class of drugs called cyclin-dependent kinase CDK inhibitors. Since then, the CDK inhibitor class has been developing rapidly, so we wanted to bring you up to date. Simply put: breast cancer is big business.